Company intelligence / Profile preview

MNI Ventures

New Haven, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

MNI Ventures is a private investment firm based in New Haven, Connecticut, that focuses on early-stage companies within the neurosciences and molecular imaging sectors. The firm was established by the founders of Molecular NeuroImaging (MNI), a prominent clinical research organization specializing in neuroimaging biomarkers that was acquired by inviCRO in 2016. MNI Ventures leverages its leadership's deep expertise in radiopharmaceutical development and clinical trial design to support startups developing novel diagnostics and therapeutics for neurodegenerative disorders. The firm typically invests in companies targeting high-unmet-need areas such as Alzheimer's and Parkinson's disease, often providing both capital and strategic guidance on imaging-based clinical endpoints.

Therapeutic areas: Neurology
Industry: Investors

Beyond the preview

Go deeper on MNI Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MNI Ventures.

Explore the full profile